Skeið
5:2 og skiftidags fasta
Hesi framleiða størstu vektartapini av fastingarskipanum, av tí minst óvæntaða orsøkin: tey skapa størstu avmarkingarnar.
Hvat skeiðini í veruleikanum fevna um
| Skeið | Fasting dagar | Inntøka á teimum døgum | Aðrir dagar |
|---|---|---|---|
| 5:2 | Tvær ikki samanhangandi dagar um vikuna | Umleið ein fjórðingur av vanligari inntøku | Óavmarkað |
| Alternativ-dag (modiferað) | Hvønn annan dag | Umleið ein fjórðingur av vanligari inntøku | Óavmarkað |
| Alternativ-dag (sannur) | Hvønn annan dag | Eingin | Óavmarkað |
Næstan allar royndir brúka modiferaðu útgávurnar. Sannur null-kalori alternativ-dag fasting er sjaldan í gransking, tí at fylgjan fellur.
Tað samanborna evidensið
Tað mest beinleiðis gagnliga greiningin samanbar alternativ-dag fasting, 5:2 og tíðavaldandi eting beinleiðis ímillum royndir [2]. Alternativ-dag fasting kom út frammanfyri. BMJ systematiska yvirlit um fasting strategiar er breitt samanhangandi [1].
Ein veruliga berandi niðurstøða: ein meta-analysa av appetit úrslitum fann, at intermittent fasting ikki framleiðir tað kompenserandi hungurskoti, sum kritikarar spáðu [3]. Fólk eta ikki álitandi aftur avmarkingina á ikki-fasting døgum.
Vættataps virkni
Hvar evidensið endar
Cochrane granskaði intermittent fasting fyri hjartakervissjúku fyribyrging og kom til niðurstøðu, at evidensið var ófullnógvandi [5] — ikki neikvøð, ófullnógvandi. Tað er ein aðrastaðni og meira heiðarlig niðurstøða enn bæði áhugafólk og kritikarar vanliga siga. Ein fyrrverandi systematiska yvirlit um fasting og vektartap kom til líknandi niðurstøður um studju-kvalitet [6].
Lívurin úrslit
Ein av teimum meira áhugaverdu játtandi niðurstøðunum: alternativ-dag fasting saman við aerobiskum venjingum betraði ikki-alkoholska feittlívur sjúku í eini randomiseraðari roynd, og samansetingin var betri enn hvørki komponentur einsamallur [7]. Líkaleiðis við tíðavaldandi eting, so vinnur fasting pluss venjing móti fasting.
At velja millum teir
- Vel á grundarlag av haldbarleika, ikki effektstødd. Størsta effektin í eini roynd er einki virði, um tú stoppar í viku seks. Fráfallstøttur í royndum er tað mest undirlesna tal í hesum litteraturinum.
- 5:2 er vanligasti kompromissið. Tvær harðar dagar um vikuna eru tolererandi fyri fleiri fólk enn hvønn annan dag.
- Fasting dagar hava brúk fyri protein. Ein fjórðingur av vanligari inntøku, sum er gjørdur av proteinum og grønum, er ein heilt aðrastaðni dagur enn ein fjórðingur gjørdur av toast.
- Ikki stakka skeiðini. At sameina alternativ-dag fasting við eini komprimeraðari vindeyga á ikki-fasting døgum er ikki prógvað og framleiðir mest ein sera stóran avmarking við sera ringari fylgju.
Vanlig spurningar
Er 5:2 betri enn 16:8?
Kann eg venja á einum fasting degi?
Hjálpir tað við feittlívur?
Mugu teir tveir fasting dagarnir vera samanhangandi?
Viðmerkingar
Hver einasta tilvísing niðanfyri bendir til upprunaliga peer-reviewed skjalið á PubMed ella gjøgnum DOI. Einki her er ein staðfesting fyri læknaligt ráð.
-
Intermittent fasting for adults with overweight or obesity Garegnani LI, Oltra G, Ivaldi D, et al. · The Cochrane database of systematic reviews · 2026 · Meta-analysis DOIPubMed 41692034Full text
-
Comparison of Different Intermittent Fasting Patterns or Different Extents of Calorie Restriction for Weight Loss and Metabolic Improvement in Adults: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials Wu X, Ding Y, Cao Q, et al. · Nutrition reviews · 2026 · Meta-analysis DOIPubMed 40367516
-
Meta-analysis and meta-regression of intermittent fasting effects on glycaemic control in type 2 diabetes: Subgroup analyses and variability Anasanti MD, Hamzah N · Diabetes & metabolic syndrome · 2025 · Meta-analysis DOIPubMed 40849220
-
The effects of intermittent fasting on sleep quality and cardiometabolic health outcomes in adults with overweight/obesity status: a systematic review and meta-analysis of randomized controlled trials Yong YN, McCubbin AJ, O'Driscoll DM, et al. · Sleep medicine reviews · 2025 · Meta-analysis DOIPubMed 41202521
-
Intermittent fasting for weight management and metabolic health: An updated comprehensive umbrella review of health outcomes Hua Z, Yang S, Li J, et al. · Diabetes, obesity & metabolism · 2025 · Systematic review DOIPubMed 39618023
-
Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis of randomised clinical trials Semnani-Azad Z, Khan TA, Chiavaroli L, et al. · BMJ (Clinical research ed.) · 2025 · Meta-analysis DOIPubMed 40533200Full text
-
A meta-analysis comparing the effectiveness of alternate day fasting, the 5:2 diet, and time-restricted eating for weight loss Elortegui Pascual P, Rolands MR, Eldridge AL, et al. · Obesity (Silver Spring, Md.) · 2023 · Meta-analysis DOIPubMed 36349432Full text
-
The Effect of Intermittent Fasting on Appetite: A Systematic Review and Meta-Analysis Elsworth RL, Monge A, Perry R, et al. · Nutrients · 2023 · Meta-analysis DOIPubMed 37299567Full text
-
Intermittent Fasting and Obesity-Related Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials Patikorn C, Roubal K, Veettil SK, et al. · JAMA network open · 2021 · Systematic review DOIPubMed 34919135Full text
-
Intermittent fasting for the prevention of cardiovascular disease Allaf M, Elghazaly H, Mohamed OG, et al. · The Cochrane database of systematic reviews · 2021 · Systematic review DOIPubMed 33512717Full text
-
Intermittent fasting and weight loss: Systematic review Welton S, Minty R, O'Driscoll T, et al. · Canadian family physician Medecin de famille canadien · 2020 · Systematic review PubMed 32060194Full text
-
Three-week Alternate-day Fasting Improves Myocardial Flow Reserve and Reduces Oxygen Use in Overweight Individuals Kjærulff MLG, Luong TV, Munk OL, et al. · The Journal of clinical endocrinology and metabolism · 2026 · Randomised controlled trial DOIPubMed 40890042
-
Comparison of acute intermittent fasting interventions on mood, hunger, sleep quality, and diet satisfaction in females: A crossover experimental design Amendola K, Harris L, Ohayon R, et al. · PloS one · 2026 · Randomised controlled trial DOIPubMed 42647528Full text
-
Alternate-day fasting elicits larger changes in fat mass than time-restricted eating in adults without obesity - A randomized clinical trial Derron N, Güntner AT, Weber IC, et al. · Clinical nutrition (Edinburgh, Scotland) · 2025 · Randomised controlled trial DOIPubMed 40945487
-
Effect of a ketogenic diet, time-restricted eating, or alternate-day fasting on weight loss in adults with obesity: a randomized clinical trial Martínez-Montoro JI, Bandera B, Gutiérrez-Bedmar M, et al. · BMC medicine · 2025 · Randomised controlled trial DOIPubMed 40598397Full text
-
Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial Ezpeleta M, Gabel K, Cienfuegos S, et al. · Cell metabolism · 2023 · Randomised controlled trial DOIPubMed 36549296Full text
-
Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity Ozcan M, Guo Z, Valenzuela Ripoll C, et al. · Cell metabolism · 2023 · Randomised controlled trial DOIPubMed 36868222Full text
-
Intermittent Fasting in Weight Loss and Cardiometabolic Risk Reduction: A Randomized Controlled Trial Chair SY, Cai H, Cao X, et al. · The journal of nursing research : JNR · 2022 · Randomised controlled trial DOIPubMed 35050952
-
Alternate Day Fasting Improves Physiological and Molecular Markers of Aging in Healthy, Non-obese Humans Stekovic S, Hofer SJ, Tripolt N, et al. · Cell metabolism · 2019 · Randomised controlled trial DOIPubMed 31471173
-
Determinants of weight loss success with alternate day fasting Varady KA, Hoddy KK, Kroeger CM, et al. · Obesity research & clinical practice · 2016 · Randomised controlled trial DOIPubMed 26385599
-
[Intermittent fasting and human metabolic health] Carvajal V, Marín A, Gihardo D, et al. · Revista medica de Chile · 2023 · Review DOIPubMed 37906749
-
Intermittent Fasting and Metabolic Health Vasim I, Majeed CN, DeBoer MD · Nutrients · 2022 · Review DOIPubMed 35276989Full text